![Yue Xing Su](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yue Xing Su
Directeur/Membre du Conseil chez
SHANGHAI MODEL ORGANISMS CENTER, INC.
Profil
Mr. Yue Xing Su is a Senior Partner at Kangjun Investment Management (Beijing) Co. Ltd. He is on the Board of Directors at Zhuhai Trinomab Pharmaceutical Co., Ltd. and Shanghai Model Organisms Center, Inc.
Postes actifs de Yue Xing Su
| Sociétés | Poste | Début |
|---|---|---|
| SHANGHAI MODEL ORGANISMS CENTER, INC. | Directeur/Membre du Conseil | 04/03/2020 |
Zhuhai Trinomab Pharmaceutical Co., Ltd.
 Zhuhai Trinomab Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops, produces and sells human antibody drugs | Directeur/Membre du Conseil | 01/04/2025 |
Kangjun Investment Management (Beijing) Co. Ltd.
 Kangjun Investment Management (Beijing) Co. Ltd. Investment ManagersFinance Kangjun Investment Management (Beijing) Co. Ltd. is an active manager. | Private Equity Investor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Shanghai Model Organisms Center, Inc.
 Shanghai Model Organisms Center, Inc. Miscellaneous Commercial ServicesCommercial Services Provides life science research and drug discovery services for cancer immunotherapy | Commercial Services |
Kangjun Investment Management (Beijing) Co. Ltd.
Kangjun Investment Management (Beijing) Co. Ltd. Investment ManagersFinance Kangjun Investment Management (Beijing) Co. Ltd. is an active manager. | Finance |
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops, produces and sells human antibody drugs | Health Technology |
